Framework for prioritizing variants of unknown significance from clinical genetic testing in kidney disease – utility of multidisciplinary approach to gather evidence of pathogenicity for Hepatocyte Nuclear Factor-1β (HNF1B) p.Arg303His

Uyenlinh L. Mirshahi, Ahana Bhan, Lotte E. Tholen, Brian Fang, Guoli Chen, Bryn Moore, Adam Cook, Prince Mohan, Kashyap Patel, Peter Igarashi, Jeroen H.F. de Baaij, Silvia Ferrè, Joost G.J. Hoenderop, David J. Carey, Alexander R. Chang
doi: https://doi.org/10.1101/2022.04.01.22273321

Article usage

Article usage: April 2022 to November 2024

AbstractFullPdf
Apr 20223902473
May 2022173923
Jun 20221421214
Jul 202277126
Aug 2022551710
Sep 20224553
Oct 20223987
Nov 202232139
Dec 202232199
Jan 202322164
Feb 202318186
Mar 202335185
Apr 202330126
May 20231686
Jun 20231583
Jul 2023661
Aug 202317168
Sep 202324137
Oct 202314123
Nov 20231183
Dec 20231445
Jan 2024745
Feb 20248112
Mar 20241766
Apr 202413227
May 20241267
Jun 20241586
Jul 20241147
Aug 2024995
Sep 20242043
Oct 20241363
Nov 2024223
Back to top
Posted April 05, 2022.
Download PDF
Data/Code
Email
Framework for prioritizing variants of unknown significance from clinical genetic testing in kidney disease – utility of multidisciplinary approach to gather evidence of pathogenicity for Hepatocyte Nuclear Factor-1β (HNF1B) p.Arg303His
Uyenlinh L. Mirshahi, Ahana Bhan, Lotte E. Tholen, Brian Fang, Guoli Chen, Bryn Moore, Adam Cook, Prince Mohan, Kashyap Patel, Peter Igarashi, Jeroen H.F. de Baaij, Silvia Ferrè, Joost G.J. Hoenderop, David J. Carey, Alexander R. Chang
medRxiv 2022.04.01.22273321; doi: https://doi.org/10.1101/2022.04.01.22273321
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area